Nurslix
— 健康促進與維護 · MCQ —

一位 65 歲病人在完成基礎疫苗接種後準備出院。哪種疫苗建議所有 65 歲及以上成人接種一次(或一個完整劑次)以預防帶狀疱疹?

A 65-year-old client is being discharged after a primary series of vaccinations. Which vaccine is recommended as a one-time dose for all adults 65 and older to prevent shingles?

  • APneumococcal polysaccharide vaccine (PPSV23)肺炎鏈球菌多醣體疫苗 (PPSV23)
  • BVaricella vaccine水痘疫苗
  • CRecombinant zoster vaccine (Shingrix)重組帶狀疱疹疫苗 (Shingrix)正確答案
  • DLive attenuated zoster vaccine (Zostavax)活性減毒帶狀疱疹疫苗 (Zostavax)
— Answer · 正確答案 —
  • C重組帶狀疱疹疫苗 (Shingrix)
— Why · 為什麼是這個答案 —

核心概念:老年人免疫接種計畫。帶狀疱疹(俗稱皮蛇)在老年群體中發病率高且易有神經痛併發症。為何正確答案 C 對:重組帶狀疱疹疫苗(Shingrix)是目前美國 CDC 建議 50 歲以上成人的首選,通常需接種兩劑,其保護效力顯著優於舊款。為何其他選項錯:選項 B 水痘疫苗是用於未曾患病的人,不等於預防帶狀疱疹;選項 A 是預防肺炎鏈球菌,與帶狀疱疹無關;選項 D 是舊型的活性減毒疫苗,目前在美國市場已逐漸被 C 選項取代,因為保護力較低且有禁忌症限制。臨床推理:護理師應告知病人,即使以前得過帶狀疱疹或打過舊款疫苗,仍應接種 Shingrix 以獲得更好的保護。

— Options · 其他選項為什麼不對 —
  • A肺炎鏈球菌多醣體疫苗 (PPSV23)

    這是肺炎鏈球菌疫苗,雖然 65 歲也建議打,但它的目標是預防肺炎而非帶狀疱疹。

  • B水痘疫苗

    水痘疫苗是預防初次感染(水痘),而帶狀疱疹疫苗是針對潛伏病毒再活化的預防。

  • C · 正確答案重組帶狀疱疹疫苗 (Shingrix)

    Shingrix 是目前公認效力最高的帶狀疱疹疫苗,50 歲以上成人不論是否曾患病都建議接種。

  • D活性減毒帶狀疱疹疫苗 (Zostavax)

    舊款活性疫苗效力隨時間下降較快且免疫不全者禁忌,現在臨床多已被 Shingrix 取代。

✦ 台美臨床差異

在美國,Shingrix 通常由商業保險或 Medicare Part D 給付。在台灣,帶狀疱疹疫苗目前多為自費項目,護理師在衛教時除了強調效益,也常需說明費用與兩劑接種的間隔時間(2-6 個月)。

English explanation

Core concept: immunization for older adults. Herpes zoster (commonly known as shingles) has a high incidence in the older population and is frequently complicated by postherpetic neuralgia. Why option C is correct: the recombinant zoster vaccine (Shingrix) is currently the preferred vaccine recommended by the U.S. CDC for adults aged 50 and older, generally given as a two-dose series, and offers significantly greater protective efficacy than the older product. Why the other options are incorrect: option B, the varicella vaccine, is intended for individuals who have never had chickenpox and is not equivalent to shingles prevention; option A protects against pneumococcal disease and is unrelated to shingles; option D is the older live attenuated vaccine, which has been progressively replaced by option C in the U.S. market because of lower efficacy and contraindications. Clinical approach: the nurse should inform the patient that even those who have previously had shingles or received the older vaccine should still receive Shingrix for better protection.

最近修訂:2026-10-06

— Related · 同分類的其他題目 —

More from Health Promotion & Maintenance

瀏覽全部 63 題 健康促進與維護 →
— Jump to another chapter —